Atlas Trials

Adding Azathioprine/Hydroxyurea Preconditioning to Alemtuzumab/TBI to Reduce Risk of Graft Failure in MSD HSCT in Adult SCD Patients

Clinical trial NCT05249452 · COMPLETED

Trial details

NCT number
NCT05249452
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
COMPLETED
Study type
OBSERVATIONAL
Sickle Cell Disease
Start date
2018-03-08
Primary completion
2023-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.